Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Mar 2023 for Oncology Institute, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ravi Yang Sarin: trading record in brief
All filings by Ravi Yang Sarin on record concern Starling Oncology, Inc. We count 5 filings; the first trade dates from 12 November 2021 and the latest from 17 March 2023.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 21 March 2023: a share grant, in Starling Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ravi Yang Sarin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
29,528 shares0Common stockSEC:0001628280-23-008831:0
22,708 shares0Common StockSEC:0001799191-22-000041:0
15,994 shares0Common stockSEC:0001628280-22-007102:0
4,109,771 sharesCommon StockSEC:0001104659-21-142489:0
4,109,771 shares0Common StockSEC:0001104659-21-140224:0
5 of 5 declarations
